Alset Inc. (NASDAQ:AEI – Get Free Report) Director Heng Fai Ambrose Chan sold 300,000 shares of the stock in a transaction that occurred on Monday, March 31st. The shares were sold at an average price of $1.03, for a total transaction of $309,000.00. Following the completion of the sale, the director now directly owns 1,253,904 shares of the company’s stock, valued at approximately $1,291,521.12. This trade represents a 19.31 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Heng Fai Ambrose Chan also recently made the following trade(s):
- On Wednesday, February 12th, Heng Fai Ambrose Chan acquired 20,244 shares of Alset stock. The stock was acquired at an average price of $1.07 per share, for a total transaction of $21,661.08.
- On Thursday, February 6th, Heng Fai Ambrose Chan bought 141,060 shares of Alset stock. The stock was acquired at an average price of $0.99 per share, for a total transaction of $139,649.40.
- On Monday, January 27th, Heng Fai Ambrose Chan acquired 100,000 shares of Alset stock. The shares were acquired at an average cost of $0.93 per share, with a total value of $93,000.00.
- On Wednesday, January 22nd, Heng Fai Ambrose Chan bought 50,000 shares of Alset stock. The shares were bought at an average cost of $0.85 per share, with a total value of $42,500.00.
Alset Stock Performance
Alset stock opened at $0.97 on Thursday. The company’s 50 day simple moving average is $0.95 and its 200-day simple moving average is $1.13. Alset Inc. has a 1 year low of $0.46 and a 1 year high of $2.61. The company has a market capitalization of $10.41 million, a price-to-earnings ratio of -0.22 and a beta of 1.24.
About Alset
Alset Inc engages in the real estate development, financial services, digital transformation technologies, biohealth activities, and consumer products businesses in the United States, Singapore, Hong Kong, Australia, and South Korea. It operates through four segments: Real Estate, Digital Transformation Technology, Biohealth, and Other Business Activities segments.
Featured Articles
- Five stocks we like better than Alset
- Trading Stocks: RSI and Why it’s Useful
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- How to Use High Beta Stocks to Maximize Your Investing Profits
- The 3 Most Talked About Investments on WallStreetBets Right Now
- How to Short Nasdaq: An Easy-to-Follow Guide
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Alset Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alset and related companies with MarketBeat.com's FREE daily email newsletter.